Determinants of unsuccessful tuberculosis treatment outcome in Northern Red Sea region, Eritrea

Abstract

Background Eritrea has achieved the global target (90%) for tuberculosis (TB) treatment success rate. Though, events of unsuccessful TB treatment outcomes (death, treatment failure, lost to follow up and not evaluated) could lead to further TB transmission and the development of resistant strains. Hence, factors related to these events should be explored and addressed. This study aims to fill the gap in evidence by identifying the determinants of unsuccessful TB treatment outcomes in Eritrea’s Northern Red Sea region. Methods A retrospective cohort study was conducted in Eritrea’s Northern Red Sea region. Data collected using a data extraction tool was analyzed using Stata version 13. Frequencies, proportions, median and standard deviations were used to describe the data. Furthermore, univariable and multivariable logistic regression analysis were performed to determine the risk factors for unsuccessful TB treatment outcomes. Crude odds ratio (COR) and adjusted odds ratio (AOR) with their 95% confidence interval (CI) presented and p-value < 0.05 was considered statistically significant. Results Among 1227 TB patients included in this study, 9.6% had unsuccessful TB treatment outcomes. In multivariable logistic regression analysis, TB cases 55–64 years old (AOR: 2.75[CI: 1.21–6.32], p = 0.016) and those ≥ 65 years old (AOR: 4.02[CI: 1.72–9.45], p = 0.001) had 2.7 and 4 times higher likelihood of unsuccessful TB treatment outcome respectively. In addition, HIV positive TB patients (AOR: 5.13[CI: 1.87–14.06], p = 0.002) were 5 times more likely to have unsuccessful TB treatment outcome. TB treatment in Ghindae Regional Referral Hospital (AOR: 5.01[2.61–9.61], p < 0.001), Massawa Hospital (AOR: 4.35[2.28–8.30], p< 0.001) and Nakfa Hospital (AOR: 2.53[1.15–5.53], p = 0.021) was associated with 5, 4 and 2.5 higher odds of unsuccessful TB treatment outcome respectively. Conclusion In this setting, old age, HIV co-infection and health facility were the independent predictors of unsuccessful TB treatment outcome.

An Insight Into Tuberculosis Patients in the Chest Clinic of North India: Epidemiological Profile and Treatment Outcomes in the Wake of COVID-19

“…This increased risk could potentially be attributed to factors such as increased virulence of the MDR TB strain, longer treatment duration, expensive drugs, ineffective drug regimens, delayed diagnosis, and outdated treatment policies [16]. We found that TB patients co-infected with HIV had nearly three times the risk of death and a lower treatment success rate compared to HIV nonreactive patients, corroborated by several other studies [17,18]. This can be explained by the compromised immune state of the patients due to HIV infection, delayed presentation and diagnosis of HIV, poor adherence to both anti-retroviral therapy (ART) and anti-tubercular treatment (ATT), as well as the presence of other co-existing conditions like neoplasms and secondary infections [17].…”

Evaluating tuberculosis treatment outcomes in Haiti from 2018 to 2019: A competing risk analysis

“…The longitudinal data of patients receiving care for TB enrolled in a surveillance program under the PNLT between 2017 and 2019 in Haiti were analyzed. Consistent with the findings of other studies, HIV-positive status was linked to poorer treatment outcomes [22] , [23] , [24] , [25] . In addition to the potential psychological effects of having to take several (HIV plus TB) pills, there are other arguments for this association.…”

“…Male patients with TB have a significantly lower chance of a successful outcome [24] . Although it is difficult to estimate the magnitude of the problem, during data quality workshops, some health care providers reported instances where male patients sell their food portions provided to them by the program instead of consuming them or used their transportation fees for other purposes, which may contribute to poor treatment outcome.…”

Effect of introducing ethambutol and integrating drugs into fixed-dose tablets on mortality in patients with tuberculosis

“…These risk factors included variables known to be associated with unfavorable outcomes, such as alcohol abuse, age, and sex, among others. [13][14][15][16] Thus, the time period was a common determinant of both the treatment and the risk factors. However, the period should not be considered as a covariate because it overlapped with the treatment being evaluated.…”